Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis
Summary: The global burden of tuberculosis (TB) is still large. The increasing incidence of drug-resistant, multidrug-resistant (MDR) (resistant to at least rifampicin and isoniazid), and extensively drug-resistant (XDR) (additionally resistant to a fluoroquinolone and kanamycin/amikacin/capreomycin...
Saved in:
Main Authors: | Suhail Ahmad (Author), Eiman Mokaddas (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait
by: Ahmad Suhail, et al.
Published: (2009) -
First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait
by: Eiman Mokaddas, et al.
Published: (2021) -
Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
by: Shulan Dong, et al.
Published: (2024) -
Evaluation of Etest and MICRONAUT-AM Assay for Antifungal Susceptibility Testing of <i>Candida auris</i>: Underestimation of Fluconazole Resistance by MICRONAUT-AM and Overestimation of Amphotericin B Resistance by Etest
by: Mohammad Asadzadeh, et al.
Published: (2024) -
Principles for designing future regimens for multidrug-resistant tuberculosis
by: Grania Brigden, et al.
Published: (2014)